Rejuvenate Biomed

Vrunstraat 153
3550 Heusden-Zolder
BE
Rejuvenate Biomed
Foundation date
02/10/2017
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing.
By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.
Upcoming events
All events-
2206 '23
Translational Research in Crops
Event by: VIB -
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB
Latest news
More news-
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
Tuesday June 6th 2023
Read more
-
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
Monday June 5th 2023
Read more
-
Biotalys continues to demonstrate strength of first biocontrol in latest global field trials
Friday June 2nd 2023
Read more